SPTLC2: A Protein Involved in Cell Signaling and Cancer Development

Target Name: SPTLC2

NCBI ID: G9517

SPTLC2: A Protein Involved in Cell Signaling and Cancer Development

SPTLC2 (SPTC2_HUMAN), also known as human SPTLC2, is a protein that is expressed in various tissues of the human body. It is a member of the S1P family of transmembrane proteins, which are known for their involvement in various cellular processes such as cell signaling, ion transport, and cytoplasmic transport. SPTLC2 has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and invasion, and is also involved in the development and progression of various diseases, including cancer. As a result, SPTLC2 has generated a lot of interest as a drug target or biomarker.

SPTLC2 is a 21-kDa protein that is expressed in various tissues of the human body, including the brain, heart, liver, and pancreas. It is primarily localized to the cytoplasm of cells and is involved in the regulation of cellular processes such as cell adhesion, migration, and invasion. SPTLC2 is a member of the S1P family of transmembrane proteins, which are known for their involvement in various cellular processes.

SPTLC2 has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and invasion. For example, SPTLC2 has been shown to be involved in the regulation of cell-cell adhesion by promoting the interaction between SPTLC2 and the protein PDGFR-尾. This interaction between SPTLC2 and PDGFR-尾 has been shown to play a role in the regulation of cell migration and the invasive properties of cancer cells.

SPTLC2 has also been shown to be involved in the regulation of cell signaling pathways. For example, SPTLC2 has been shown to play a role in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of various cellular processes such as cell growth, survival, and angiogenesis.

SPTLC2 has also been shown to be involved in the regulation of cellular cytoplasmic transport. For example, SPTLC2 has been shown to play a role in the regulation of the trafficking of various cellular proteins to and from the endoplasmic reticulum, a process that is involved in the regulation of protein synthesis and degradation.

In addition to its role in cellular processes, SPTLC2 has also been shown to be involved in the development and progression of various diseases, including cancer. For example, SPTLC2 has been shown to be involved in the regulation of the angiogenesis that occurs during the development of cancer, by promoting the growth and survival of cancer cells.

Due to its involvement in various cellular processes and its association with the development and progression of diseases, SPTLC2 has generated a lot of interest as a drug target or biomarker. Researchers have been exploring the potential therapeutic uses of SPTLC2 as a drug target, with a focus on developing small molecules that can inhibit the activity of SPTLC2 and its downstream targets.

One of the main challenges in developing new drugs that target SPTLC2 is its complex structure and the fact that it is expressed in various tissues of the human body. Researchers have been unable to predict the exact mechanism of action of new drugs and have had difficulty in designing effective inhibitors. However, recent studies have provided some insights into the molecular mechanisms that are involved in the regulation of SPTLC2 and its downstream targets.

SPTLC2 is a protein that is involved in the regulation of various cellular processes, including cell adhesion, migration, and invasion. It is a member of the S1P family of transmembrane proteins and has been shown to play a role in the regulation of cellular processes such as

Protein Name: Serine Palmitoyltransferase Long Chain Base Subunit 2

Functions: Serine palmitoyltransferase (SPT). The heterodimer formed with LCB1/SPTLC1 constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2-SPTSSA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC2-SPTSSB complex displays a preference for C18-CoA substrate. Plays an important role in de novo sphyngolipid biosynthesis which is crucial for adipogenesis (By similarity)

More Common Targets